Haemonetics (HAE) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $75.00 --0%
EPS Growth %: -0.9%
Financial Fact:
Gross profit: 104.25M
Today's EPS Names:
CRMT, FOMI, FLES, More
EPS Growth %: -0.9%
Financial Fact:
Gross profit: 104.25M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.77, $0.07 better than the analyst estimate of $0.70. Revenue for the quarter came in at $304 million versus the consensus estimate of $290.79 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Regional Director in US Adjusts List of Top Names
- Evercore ISI Upgrades Werner Enterprises (WERN) to In Line
- Evercore ISI on ServiceNow (NOW): 'Thoughts Into F2Q & Takeaways From Quarterly Partner Survey'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
